1 School of Women's and Children's Health, Discipline of Paediatrics, UNSW Medicine, University of New South Wales , Sydney, Australia .
2 Sydney Youth Cancer Service , Sydney, Australia .
J Adolesc Young Adult Oncol. 2016 Sep;5(3):232-9. doi: 10.1089/jayao.2015.0056. Epub 2016 Mar 16.
In Australia and New Zealand, there has not been a national systematic development of oncofertility services for cancer patients of reproductive age although many cancer and fertility centers have independently developed services. A number of barriers exist to the development of these services, including a lack of clear referral pathways, a lack of communication between clinicians and patients about fertility preservation, differences in the knowledge base of clinicians about the risk of cancer treatment causing infertility and fertility preservation options, a lack of national health insurance funding covering all aspects of fertility preservation, and storage costs and cultural, religious, and ethical barriers. The development of strategies to overcome these barriers is a high priority for oncofertility care to ensure that equitable access to the best standard of care is available for all patients.
The FUTuRE Fertility Research Group led a collaborative consultation process with the Australasian Oncofertility Consumer group and oncofertility specialists to explore consumers' experiences of oncofertility care. Consumers participated in qualitative focus group meetings to define and develop a model of consumer driven or informed "gold standard oncofertility care" with the aim of putting together a Charter that specifically described this.
The finalized Australasian Oncofertility Consortium Charter documents eight key elements of gold standard oncofertility care that will be used to monitor the implementation of oncofertility services nationally, to ensure that these key elements are incorporated into standard practice over time.
在澳大利亚和新西兰,尽管许多癌症和生育中心已经独立开发了服务,但针对育龄癌症患者的肿瘤生育力服务尚未在全国范围内进行系统开发。这些服务的发展存在许多障碍,包括缺乏明确的转诊途径、临床医生和患者之间缺乏关于生育力保存的沟通、临床医生对癌症治疗导致不孕和生育力保存选择的风险的知识库存在差异、缺乏涵盖生育力保存所有方面的国家健康保险资金、以及存储成本和文化、宗教和伦理障碍。制定克服这些障碍的策略是肿瘤生育力护理的当务之急,以确保所有患者都能公平获得最佳护理标准。
FUTuRE 生育力研究小组与澳大拉西亚肿瘤生育力消费者小组和肿瘤生育力专家合作,进行了协作咨询,以探讨消费者对肿瘤生育力护理的体验。消费者参加了定性焦点小组会议,以确定并开发一种由消费者驱动或知情的“黄金标准肿瘤生育力护理”模型,旨在制定一份专门描述这一点的宪章。
最终的澳大拉西亚肿瘤生育力联盟宪章文件记录了黄金标准肿瘤生育力护理的八个关键要素,这些要素将用于监测全国范围内的肿瘤生育力服务的实施情况,以确保随着时间的推移将这些关键要素纳入标准实践中。